Delivery Technologies Application Outlook News Today : Breaking News, Live Updates & Top Stories | Vimarsana

 size is expected
to reach USD 7.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected
to expand at a CAGR of 15.1%
from 2021 to 2028. Technological advancements in viral vectors, a growing pipeline of advanced therapies, and a rising number of regulatory approvals for advance therapy products are some key driving forces of the market.
Key suggestions from the report:
The wide implementation of biological gene delivery technologies in clinical usage owing to their high efficiency and specificity has resulted in the segment s largest revenue share in 2020
Gene therapy development is the key revenue-generating application in the 2020 market owing to constantly expanding pipeline programs of therapies against life-threatening conditions coupled with the recent success of CAR-T therapies ....

United States , South Africa , South Korea , San Francisco , Oxford Biomedica , Asia Pacific , Sherry James , Origene Technologies Inc , View Research Inc , Bio Rad Laboratories Inc , View Research , Horizon Discovery Group Co , Takara Bio Inc , Catalent Inc , Thermo Fisher Scientific Inc , Promega Corporation , Grand View Research , North America , Delivery Technologies Market Size , Trends Analysis Report By Mode , Gene Therapy , Cell Therapy , Segment Forecasts , Delivery Technologies Mode Outlook , Delivery Technologies Application Outlook , Delivery Technologies Method Outlook ,